Check Out What Whales Are Doing With PFE
Check Out What Whales Are Doing With PFE
Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer.
有大量资金可以花的鲸鱼对辉瑞采取了明显的看涨立场。
Looking at options history for Pfizer (NYSE:PFE) we detected 8 trades.
查看辉瑞（纽约证券交易所代码：PFE）的期权历史记录，我们发现了8笔交易。
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
如果我们考虑每笔交易的具体情况，可以准确地说，50％的投资者以看涨的预期开启交易，50％的投资者持看跌预期。
From the overall spotted trades, 3 are puts, for a total amount of $165,037 and 5, calls, for a total amount of $321,380.
在已发现的全部交易中，有3笔是看跌期权，总额为165,037美元，5笔是看涨期权，总额为321,380美元。
What's The Price Target?
目标价格是多少？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter.
分析这些合约的交易量和未平仓合约，看来大型企业一直在关注辉瑞在过去一个季度的价格范围从20.0美元到30.0美元不等。
Analyzing Volume & Open Interest
分析交易量和未平仓合约
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pfizer's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pfizer's substantial trades, within a strike price spectrum from $20.0 to $30.0 over the preceding 30 days.
评估交易量和未平仓合约是期权交易的战略步骤。这些指标揭示了辉瑞期权在指定行使价下的流动性和投资者对辉瑞期权的兴趣。即将发布的数据可视化了与辉瑞的大量交易相关的看涨期权和看跌期权的交易量和未平仓合约的波动，在过去30天内，行使价范围从20.0美元到30.0美元不等。
Pfizer Call and Put Volume: 30-Day Overview
辉瑞看涨期权和看跌期权交易量：30天概述
Biggest Options Spotted:
发现的最大选择：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| PFE | CALL | SWEEP | BULLISH | 01/16/26 | $30.00 | $146.4K | 16.3K | 521 |
| PFE | PUT | SWEEP | BULLISH | 02/23/24 | $25.00 | $92.1K | 129 | 5.7K |
| PFE | CALL | TRADE | BEARISH | 01/16/26 | $20.00 | $66.4K | 3.2K | 186 |
| PFE | PUT | SWEEP | BEARISH | 01/19/24 | $30.00 | $41.7K | 45.3K | 210 |
| PFE | CALL | TRADE | BEARISH | 01/17/25 | $30.00 | $36.4K | 22.1K | 658 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|
| PFE | 打电话 | 扫 | 看涨 | 01/16/26 | 30.00 美元 | 146.4 万美元 | 16.3K | 521 |
| PFE | 放 | 扫 | 看涨 | 02/23/24 | 25.00 美元 | 92.1 万美元 | 129 | 5.7K |
| PFE | 打电话 | 贸易 | 粗鲁的 | 01/16/26 | 20.00 美元 | 66.4 万美元 | 3.2K | 186 |
| PFE | 放 | 扫 | 粗鲁的 | 01/19/24 | 30.00 美元 | 41.7 万美元 | 45.3K | 210 |
| PFE | 打电话 | 贸易 | 粗鲁的 | 01/17/25 | 30.00 美元 | 36.4 万美元 | 22.1K | 658 |
About Pfizer
关于辉瑞
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
辉瑞是全球最大的制药公司之一，年销售额接近500亿美元（不包括 COVID-19 产品的销售）。虽然它历来销售许多类型的医疗保健产品和化学品，但现在处方药和疫苗占销售额的大部分。最畅销的产品包括肺炎球菌疫苗Prevnar 13、抗癌药物Ibrance和心血管治疗Eliquis。辉瑞在全球销售这些产品，国际销售额占总销售额的近50％。在国际销售中，新兴市场是主要贡献者。
Following our analysis of the options activities associated with Pfizer, we pivot to a closer look at the company's own performance.
在分析了与辉瑞相关的期权活动之后，我们将转向仔细研究公司自身的表现。
Where Is Pfizer Standing Right Now?
辉瑞现在在哪里？
- Currently trading with a volume of 16,271,070, the PFE's price is down by -1.67%, now at $27.68.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 12 days.
- 目前的交易量为16,271,070美元，PFE的价格下跌了-1.67％，目前为27.68美元。
- RSI读数表明，该股目前在超买和超卖之间处于中立状态。
- 预计财报将在12天后发布。
What Analysts Are Saying About Pfizer
分析师对辉瑞的看法
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $38.5.
在过去的一个月中，两位行业分析师分享了他们对该股的见解，提出平均目标价为38.5美元。
- An analyst from TD Cowen has revised its rating downward to Market Perform, adjusting the price target to $32.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $45.
- 道明考恩的一位分析师已将其评级下调至市场表现，将目标股价调整为32美元。
- 坎托·菲茨杰拉德的一位分析师谨慎地将其评级下调至增持，将目标股价定为45美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比，期权是一种风险更高的资产，但它们具有更高的盈利潜力。严肃的期权交易者通过每天进行自我教育、扩大交易规模、遵循多个指标以及密切关注市场来管理这种风险。
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
如果您想随时了解辉瑞的最新期权交易，Benzinga Pro会为您提供实时期权交易提醒。